211 related articles for article (PubMed ID: 23526079)
1. CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
Shen HB; Gu ZQ; Jian K; Qi J
Tumour Biol; 2013 Jun; 34(3):1839-45. PubMed ID: 23526079
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
3. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer.
Xu Q; Wang Z; Chen X; Duan W; Lei J; Zong L; Li X; Sheng L; Ma J; Han L; Li W; Zhang L; Guo K; Ma Z; Wu Z; Wu E; Ma Q
Oncotarget; 2015 Mar; 6(7):4717-32. PubMed ID: 25605248
[TBL] [Abstract][Full Text] [Related]
4. CXCL12-CXCR4 promotes proliferation and invasion of pancreatic cancer cells.
Shen B; Zheng MQ; Lu JW; Jiang Q; Wang TH; Huang XE
Asian Pac J Cancer Prev; 2013; 14(9):5403-8. PubMed ID: 24175834
[TBL] [Abstract][Full Text] [Related]
5. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
7. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
Uygur B; Wu WS
Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
[TBL] [Abstract][Full Text] [Related]
8. Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer.
Pfeiffer M; Hartmann TN; Leick M; Catusse J; Schmitt-Graeff A; Burger M
Br J Cancer; 2009 Jun; 100(12):1949-56. PubMed ID: 19455144
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
[TBL] [Abstract][Full Text] [Related]
10. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of CXCL12/CXCR4 in rat urinary bladder with cyclophosphamide-induced cystitis.
Arms L; Girard BM; Vizzard MA
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F589-600. PubMed ID: 20032115
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin-interacting protein suppresses bladder carcinogenesis.
Nishizawa K; Nishiyama H; Matsui Y; Kobayashi T; Saito R; Kotani H; Masutani H; Oishi S; Toda Y; Fujii N; Yodoi J; Ogawa O
Carcinogenesis; 2011 Oct; 32(10):1459-66. PubMed ID: 21771725
[TBL] [Abstract][Full Text] [Related]
13. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
Tu CC; Arnolds KL; O'Connor CM; Spencer JV
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
[TBL] [Abstract][Full Text] [Related]
15. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
16. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo.
Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C
Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migration.
Ierano C; Basseville A; To KK; Zhan Z; Robey RW; Wilkerson J; Bates SE; Scala S
Cancer Biol Ther; 2013 Feb; 14(2):175-83. PubMed ID: 23192271
[TBL] [Abstract][Full Text] [Related]
18. Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
Zhang Y; Wang JH; Liu B; Qu PB
Asian Pac J Cancer Prev; 2013; 14(6):3847-50. PubMed ID: 23886194
[TBL] [Abstract][Full Text] [Related]
19. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer.
Wang X; Cao Y; Zhang S; Chen Z; Fan L; Shen X; Zhou S; Chen D
Oncotarget; 2017 May; 8(22):36149-36160. PubMed ID: 28193907
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]